Do multiple mycotoxins place overlapping demands on liver detoxification, glutathione defenses, bile handling, and renal clearance?

Mycotoxins such as ochratoxin A (OTA), aflatoxins, fumonisins, and trichothecenes frequently co-occur in the environment, placing overlapping demands on hepatic processing, cellular antioxidant defenses, and excretory pathways.

Hepatic biotransformation and cellular defenses

• Enzymatic saturation: Aflatoxin B1 is bioactivated by CYP1A2 and CYP3A4/3A5 and detoxified via GST-mediated conjugation with glutathione (GSH). Because OTA also utilizes CYP-mediated pathways, concurrent exposure can saturate these metabolic networks.
• Glutathione depletion and ferroptosis: These toxins deplete intracellular GSH and downregulate GCLC, a key enzyme in glutathione synthesis. This impairs the glutathione-dependent GPX4 system, triggering lipid peroxidation and driving cells toward ferroptosis (a form of programmed cell death).

Biliary and renal clearance mechanisms

• Hepatobiliary transporter saturation: Biliary excretion of OTA requires basolateral uptake via OATPs and subsequent canalicular efflux via MRP2. Co-exposure can saturate these efflux systems, reducing biliary clearance and prolonging systemic exposure.
• Renal tubular accumulation: Renal clearance relies on active tubular secretion. OTA is a high-affinity substrate for the basolateral uptake transporters hOAT1 and hOAT3. Co-exposure to multiple toxins alters the expression and localization of these transporters and apical efflux pumps (such as BCRP and MRPs), leading to cellular toxin accumulation and enhanced nephrotoxicity.

Bottom line

• Co-exposure to multiple mycotoxins creates a multi-system bottleneck by saturating critical transport proteins (OAT1/OAT3, MRP2, BCRP) and depleting glutathione-dependent GPX4 defenses, which accelerates lipid peroxidation and cellular damage.